Diva Kakar Chander

Array ( [id] => 6716476 [patent_doc_number] => 20030027824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Pyrazolopyrimidinones for the treatment of female sexual dysfunction' [patent_app_type] => new [patent_app_number] => 10/202962 [patent_app_country] => US [patent_app_date] => 2002-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3389 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027824.pdf [firstpage_image] =>[orig_patent_app_number] => 10202962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664566 [patent_doc_number] => 20030203892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications' [patent_app_type] => new [patent_app_number] => 10/200599 [patent_app_country] => US [patent_app_date] => 2002-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16403 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203892.pdf [firstpage_image] =>[orig_patent_app_number] => 10200599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847553 [patent_doc_number] => 20030166720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications' [patent_app_type] => new [patent_app_number] => 10/200600 [patent_app_country] => US [patent_app_date] => 2002-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13239 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166720.pdf [firstpage_image] =>[orig_patent_app_number] => 10200600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395443 [patent_doc_number] => 20040018192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Integrin expression inhibitors' [patent_app_type] => new [patent_app_number] => 10/181562 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 57737 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018192.pdf [firstpage_image] =>[orig_patent_app_number] => 10181562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6705894 [patent_doc_number] => 20030152628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release core' [patent_app_type] => new [patent_app_number] => 10/194507 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12457 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152628.pdf [firstpage_image] =>[orig_patent_app_number] => 10194507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6762019 [patent_doc_number] => 20030125381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Inhibition of two-component signal transduction systems' [patent_app_type] => new [patent_app_number] => 10/168141 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5731 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125381.pdf [firstpage_image] =>[orig_patent_app_number] => 10168141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702164 [patent_doc_number] => 20030225044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Method to increase serum levels of vitamins in animals including humans' [patent_app_type] => new [patent_app_number] => 10/162111 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6401 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225044.pdf [firstpage_image] =>[orig_patent_app_number] => 10162111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6858877 [patent_doc_number] => 20030089885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids' [patent_app_type] => new [patent_app_number] => 10/127563 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6904 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20030089885.pdf [firstpage_image] =>[orig_patent_app_number] => 10127563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809543 [patent_doc_number] => 20030199482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Therapeutic combinations for cardiovascular and inflammatory indications' [patent_app_type] => new [patent_app_number] => 10/107809 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61565 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199482.pdf [firstpage_image] =>[orig_patent_app_number] => 10107809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6782599 [patent_doc_number] => 20030064046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'High internal aqueous phase water-in-oil type emulsion cosmetic composition' [patent_app_type] => new [patent_app_number] => 10/106847 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10687 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064046.pdf [firstpage_image] =>[orig_patent_app_number] => 10106847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261951 [patent_doc_number] => 20020187977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Methods for restoring cognitive function following systemic stress' [patent_app_type] => new [patent_app_number] => 10/099537 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12365 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187977.pdf [firstpage_image] =>[orig_patent_app_number] => 10099537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6324273 [patent_doc_number] => 20020197309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Method for lowering blood glucose' [patent_app_type] => new [patent_app_number] => 10/097360 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6227 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197309.pdf [firstpage_image] =>[orig_patent_app_number] => 10097360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838444 [patent_doc_number] => 20030035784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Hair cosmetic, aminocarboxylic acid amide and method for producing the same' [patent_app_type] => new [patent_app_number] => 10/086873 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14012 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035784.pdf [firstpage_image] =>[orig_patent_app_number] => 10086873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668299 [patent_doc_number] => 20030113282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Low residue anhydrous antiperspirant stick composition' [patent_app_type] => new [patent_app_number] => 10/021210 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5081 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113282.pdf [firstpage_image] =>[orig_patent_app_number] => 10021210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 733164 [patent_doc_number] => 07037945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Method of inhibiting formation of Neisseria gonorrhea and Neisseria meningiditis ' [patent_app_type] => utility [patent_app_number] => 10/013760 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3804 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037945.pdf [firstpage_image] =>[orig_patent_app_number] => 10013760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001063 [patent_doc_number] => 20010053780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Daily treatment for erectile dysfunction using a PDE5 inhibitor' [patent_app_type] => new [patent_app_number] => 09/834442 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8740 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053780.pdf [firstpage_image] =>[orig_patent_app_number] => 09834442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947756 [patent_doc_number] => 20010021390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Prolongation of chemical activity of flavorants and therapeutics on mucin coated surfaces using mucin adhering amphiphilic substances' [patent_app_type] => new [patent_app_number] => 09/774484 [patent_app_country] => US [patent_app_date] => 2001-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 2970 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021390.pdf [firstpage_image] =>[orig_patent_app_number] => 09774484 [rel_patent_id] =>[rel_patent_doc_number] =>)